REQUEST A DEMO
Total
USD $0.00
Search more companies

Institute Of Pharmacological Research Sp. z o.o. (Poland)

Main Activities: All Other Food Manufacturing
Full name: Institute Of Pharmacological Research Sp. z o.o. Profile Updated: August 26, 2023
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English & Polish Download a sample report

Institute Of Pharmacological Research Sp. z o.o. is a company in Poland, with a head office in Warsaw. The company operates in the All Other Food Manufacturing sector. The company was established on October 16, 2020. In its most recent financial highlights, the company reported a net sales revenue increase of 350.53% in 2022. A growth of 108.93% was recorded in its total assets. Institute Of Pharmacological Research Sp. z o.o.’s net profit margin increased by 80.82% in 2022.

Headquarters
Ul. Sienna 83/218
Warsaw; Mazowieckie; Postal Code: 00-815

Contact Details: Purchase the Institute Of Pharmacological Research Sp. z o.o. report to view the information.

Basic Information
Outstanding Shares:
Purchase the Institute Of Pharmacological Research Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Institute Of Pharmacological Research Sp. z o.o. report to view the information.
Incorporation Date:
October 16, 2020
Key Executives
Purchase this report to view the information.
President
Ownership Details
Purchase this report to view the information.
90%
Purchase this report to view the information.
10%
Company Performance
Financial values in the chart are available after Institute Of Pharmacological Research Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
350.53%
Total operating revenue
350.52%
Operating profit (EBIT)
-103.97%
EBITDA
-101.79%
Net Profit (Loss) for the Period
-115.47%
Total assets
108.93%
Total equity
-199.08%
Operating Profit Margin (ROS)
80.13%
Net Profit Margin
80.82%
Return on Equity (ROE)
-25.83%
Debt to Equity Ratio
20.75%
Quick Ratio
0.65%
Cash Ratio
0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?